Select Medical (NYSE:SEM) Downgraded by Benchmark to Hold

Benchmark cut shares of Select Medical (NYSE:SEM) from a buy rating to a hold rating in a research report released on Monday, MarketBeat reports.

Several other research analysts also recently commented on the stock. Royal Bank of Canada raised their price target on shares of Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Bank of America began coverage on Select Medical in a research report on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target on the stock. Finally, StockNews.com lowered shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Three investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $40.75.

Select Medical Price Performance

Shares of NYSE SEM opened at $20.35 on Monday. The firm has a market cap of $2.63 billion, a price-to-earnings ratio of 9.51, a price-to-earnings-growth ratio of 1.73 and a beta of 1.42. The stock has a fifty day simple moving average of $34.39 and a two-hundred day simple moving average of $34.80. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. Select Medical has a 1-year low of $20.00 and a 1-year high of $40.98.

Select Medical (NYSE:SEM) last issued its earnings results on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.36 by $0.07. The business had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business’s revenue for the quarter was up 5.7% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.46 EPS. Analysts anticipate that Select Medical will post 2.16 earnings per share for the current year.

Select Medical Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, November 26th. Shareholders of record on Wednesday, November 13th were given a dividend of $0.125 per share. This represents a $0.50 dividend on an annualized basis and a yield of 2.46%. The ex-dividend date was Wednesday, November 13th. Select Medical’s payout ratio is currently 23.36%.

Institutional Investors Weigh In On Select Medical

Several institutional investors and hedge funds have recently modified their holdings of SEM. Hexagon Capital Partners LLC raised its stake in Select Medical by 528.7% in the second quarter. Hexagon Capital Partners LLC now owns 767 shares of the health services provider’s stock worth $27,000 after buying an additional 645 shares in the last quarter. Quarry LP purchased a new position in shares of Select Medical in the 3rd quarter valued at approximately $30,000. Transcendent Capital Group LLC bought a new stake in shares of Select Medical during the second quarter valued at approximately $35,000. Canada Pension Plan Investment Board purchased a new stake in Select Medical in the second quarter worth $39,000. Finally, DekaBank Deutsche Girozentrale bought a new position in Select Medical in the second quarter worth $60,000. 89.48% of the stock is owned by hedge funds and other institutional investors.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.